Title |
Identifying cisplatin-induced kidney damage in paediatric oncology patients
|
---|---|
Published in |
Pediatric Nephrology, August 2017
|
DOI | 10.1007/s00467-017-3765-6 |
Pubmed ID | |
Authors |
Chris D. Barton, Barry Pizer, Caroline Jones, Louise Oni, Munir Pirmohamed, Daniel B. Hawcutt |
Abstract |
Cisplatin is one chemotherapeutic agent used to treat childhood cancer in numerous treatment protocols, including as a single agent. It is likely to remain in clinical use over the long term. However, cisplatin-related toxicities, including neurotoxicity and nephrotoxicity, are common, affecting treatment, day-to-day life and survival of such children. With one in 700 young adults having survived childhood cancer, patients who have completed chemotherapy that includes cisplatin can experience long-term morbidity due to treatment-related adverse reactions. A better understanding of these toxicities is essential to facilitate prevention, surveillance and management. This review article discusses the effect of cisplatin-induced nephrotoxicity (Cis-N) in children and considers the underlying mechanisms. We focus on clinical features and identification of Cis-N (e.g. investigations and biomarkers) and the importance of magnesium homeostasis and supplementation. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 22% |
United States | 2 | 22% |
Mexico | 1 | 11% |
Unknown | 4 | 44% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 6 | 67% |
Practitioners (doctors, other healthcare professionals) | 2 | 22% |
Science communicators (journalists, bloggers, editors) | 1 | 11% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 67 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 12 | 18% |
Student > Ph. D. Student | 8 | 12% |
Student > Bachelor | 7 | 10% |
Researcher | 6 | 9% |
Other | 5 | 7% |
Other | 8 | 12% |
Unknown | 21 | 31% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 19 | 28% |
Nursing and Health Professions | 10 | 15% |
Pharmacology, Toxicology and Pharmaceutical Science | 9 | 13% |
Biochemistry, Genetics and Molecular Biology | 3 | 4% |
Computer Science | 1 | 1% |
Other | 1 | 1% |
Unknown | 24 | 36% |